Aurora Spine, LLC, in a partnership with Axxcess Health Care Group, has raised $2 million in a series “A” investment round. According to Ken Gross, CFO of Aurora Spine, the Carlsbad, California, company expects to raise a total of $5 million.
Aurora Spine Raises $2 Million
1 min read Premium comments
Secondary
Aurora Spine plans to use the Axxcess Capital Healthcare Group financing to fuel Aurora’s pre-launch phase and fund multiple technologies currently under development in the areas of fusion, minimally invasive surgery, and biomaterials. Officials of Aurora Spine see Axxcess as a key, strategic funding partner working to bring highly “disruptive technology” from Aurora Spine to the medical industry. They note that Axxcess has over 60 years of industry experience, and has successfully launched numerous companies over the past five years. “Together, we believe Aurora and Axxcess will bring much needed innovation to the spinal implant market, ” Gross said.
Tim Snodgrass, president of Axxcess, responded, “Aurora Spine is an exciting company with a unique vision for the future of spinal devices. Its experienced executive team has the industry ‘know how’ to execute that vision today. We are excited about the opportunity to work together.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.